関連する実験動画
Updated: Feb 19, 2026
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
1.8K
慢性腎疾患の進行を遅らせるための多要素介入の有効性 G3-G4段階:体系的レビューとメタ解析
Chenxinan Ma1, Lei Wu2, Yaxi Li3
1Program in Health Services Research & Population Health, Duke-NUS Medical School, Singapore, Singapore, 169857.
Clinical journal of the American Society of Nephrology : CJASN
|February 17, 2026
まとめ
多成分介入 (MCI) は,G3-G4段階における慢性腎疾患 (CKD) の進行を遅らせ,血糖コントロールを改善する可能性を示しています. しかし,証拠の確実性は低いから中等で,さらなる高品質な研究が必要である.
科学分野:
- ネフロロジーはネフロロジーを用います.
- 公衆衛生は公衆衛生である.
- 根拠に基づいた医学は,証拠に基づいた医療です.
背景:
- 慢性腎疾患 (CKD) ステージG3-G4の管理には,多くの場合,多成分介入 (MCI) が含まれる.
- CKDの進行を遅らせるMCIの有効性に関する集団的証拠の体系的な評価は欠けている.
研究 の 目的:
- CKDの進行を遅らせるMCIの有効性を体系的にレビューし,メタ分析する.
- CKD G3-G4.4段階の患者の健康上の結果に対するMCIの影響を評価する.
主な方法:
- 主要なデータベース (PubMed,Embase,CENTRAL,Web of Science,CINAHL) の間で2025年7月30日まで体系的な文献検索を行いました.
- CKD G3-G4.4患者のMCI (≥6ヶ月間) のランダム化比較試験 (RCT) を含む.
- ランダム効果メタアナリシスで,推定グルメルフィルタレーション率 (eGFR) および二次アウトカムに対するMCIの影響を評価する.
主要な成果:
- 36,296人の患者を対象とした19件のRCTを分析した.
- MCIは,eGFR (MD=1.18) とeGFRの傾き (MD=0.61) のわずかな改善を示し,HbA1cの適度な減少 (MD=-0.26) を示した.
- アルブミヌリア,血圧,または有害事象に関する有意な効果は見つかりませんでした.
結論:
- MCIは,CKD G3-G4患者のCKD進行を遅らせ,血糖コントロールを改善する役割を果たす可能性があります.
- 重要なアウトカムに関する証拠の低から中程度の確実性は,控えめな臨床的関連性を示唆しています.
- MCIの有効性,費用対効果,およびスケーラビリティを確認するには,高品質の研究が必要です.
関連する概念動画
01:28Chronic Kidney Disease III: Interprofessional Care
494
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
494
01:18Chronic Kidney Disease IV: Nursing Management
422
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
422
01:24Chronic Kidney Disease II: Clinical Manifestations
730
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
730
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
248
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
248
01:25Chronic Kidney Disease I: Introduction
798
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
798
01:20Acute Kidney Injury V: Interprofessional Care
370
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
370